On Friday, Ventyx Biosciences Inc (NASDAQ: VTYX) was -5.08% drop from the session before settling in for the closing price of $1.97. A 52-week range for VTYX has been $1.79 – $11.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 36.44%. With a float of $53.83 million, this company’s outstanding shares have now reached $59.24 million.
Let’s look at the performance matrix of the company that is accounted for 80 employees. In terms of profitability, gross margin is -4.74%, operating margin of -15258.18%, and the pretax margin is -14175.09%.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ventyx Biosciences Inc stocks. The insider ownership of Ventyx Biosciences Inc is 22.62%, while institutional ownership is 63.94%. The most recent insider transaction that took place on Apr 02 ’24, was worth 8,921. In this transaction CHIEF BUSINESS OFFICER of this company sold 1,651 shares at a rate of $5.40, taking the stock ownership to the 284,999 shares. Before that another transaction happened on Apr 02 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 1,651 for $5.40, making the entire transaction worth $8,921. This insider now owns 264,998 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.79 earnings per share (EPS) during the time that was better than consensus figure (set at -0.8) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.44% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
You can see what Ventyx Biosciences Inc (VTYX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 23.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.15 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (NASDAQ: VTYX) saw its 5-day average volume 1.15 million, a negative change from its year-to-date volume of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 8.98%. Additionally, its Average True Range was 0.13.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 5.63%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.61% in the past 14 days, which was lower than the 80.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2284, while its 200-day Moving Average is $3.5680. Nevertheless, the first resistance level for the watch stands at $1.9567 in the near term. At $2.0433, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0867. If the price goes on to break the first support level at $1.8267, it is likely to go to the next support level at $1.7833. The third support level lies at $1.6967 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are 70,711K outstanding shares of the company, which has a market capitalization of 125.52 million. As of now, sales total 0 K while income totals -192,960 K. Its latest quarter income was 0 K while its last quarter net income were -35,250 K.
